TOFACITINIB, AN ORAL JANUS KINASE INHIBITOR, IN THE TREATMENT OF ULCERATIVE COLITIS: OPEN-LABEL, LONG-TERM EXTENSION STUDY

Gary R. Lichtenstein  1     Edward V Loftus Jr  2     Stuart Bloom  3     Nervin Lawendy  4     Gary S. Friedman     Haiying Zhang     Wenjin Wang     Andrew J. Thorpe     Chudy I. Nduaka     Chinyu Su    
1 Perelman School of Medicine of the University of Pennsylvania,Division of Gastroenterology,Philadelphia,United States of America
2 Mayo Clinic,Division of Gastroenterology and Hepatology,Rochester,United States of America
3 University College London Hospitals NHS Foundation Trust,London,United Kingdom
4 Pfizer Inc,Collegeville,United State

Conference
25th UEG Week 2017

Citation
United European Gastroenterology Journal 2017; 5 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing